BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan C, Zhao X, Wangmo D, Alshareef D, Gates TJ, Subramanian S. Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer. Pharmacol Ther 2021;:107981. [PMID: 34480964 DOI: 10.1016/j.pharmthera.2021.107981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Siddiqui R, Boghossian A, Alharbi AM, Alfahemi H, Khan NA. The Pivotal Role of the Gut Microbiome in Colorectal Cancer. Biology 2022;11:1642. [DOI: 10.3390/biology11111642] [Reference Citation Analysis]
2 Chen H, Zheng M, Zhang W, Long Y, Xu Y, Yuan M. Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/6404853] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tuo LY, Zhang ZR, Xin H, Chu X, Xu W. Study of Correlation between Intestinal Microbiota and Traditional Chinese Medicine Syndrome of Patients with Colon Cancer. Evid Based Complement Alternat Med 2022;2022:2989456. [PMID: 35859998 DOI: 10.1155/2022/2989456] [Reference Citation Analysis]
4 Hu LF, Lan HR, Huang D, Li XM, Jin KT. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? Front Oncol 2021;11:769305. [PMID: 34888246 DOI: 10.3389/fonc.2021.769305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]